Navigation Links
Paradigm Business Update as of November 30, 2011
Date:12/6/2011

SALT LAKE CITY, Dec. 6, 2011 /PRNewswire/ -- Paradigm Medical Industries, Inc. (OTC.PK:PDMI) announced that it is continuing to move forward with its growth and expansion plans in spite of the limited working capital and market concerns it has had to confront.

"The past three years have tested the mettle of Paradigm, its shareholders and remaining loyal employees. As the very difficult year of 2011 comes to a close, Paradigm remains hopeful it will see the DTC "chill" removed on its stock, new financial support, and a new plan to allow Paradigm to move forward in 2012 and beyond,"  said Stephen Davis, Paradigm President and Chief Executive Officer.

Paradigm Medical is also moving ahead in its effort to re-certify its new facility for ISO, CE and FDA regulatory standards. When completed, this effort will result in increased world wide availability of Paradigm's manufactured products.   It is and will remain Paradigm's intent to be totally complaint with all FDA requirements in the United States and all other regulatory requirements internationally.

Paradigm is also directly supporting the new 510(k) application being submitted to the Federal Drug Administration (FDA) for the Paramax™. "Paradigm will be working closely with this new application process with Costruzione Strumenti Oftalmici (CSO), its Italian partner which manufactures the Paramax™.  Paradigm is hopeful the FDA review will be a more favorable response this time," said Mr. Davis.  

Mr. Davis also noted: "The Paramax represents one of the most reliable and durable early glaucoma diagnostic devices available in the U.S. market.  It provides the earliest diagnosis of glaucoma available, potentially saving the vision for many who would have otherwise lost it."

About Paradigm Medical Industries, Inc.Paradigm Medical Industries, Inc. is a medical device company that develops, manufactures and distributes ophthalmic diagnostic instruments and related products for early detection of glaucoma and other eye disorders. The Company's primary objective is to capture a niche market within the glaucoma and ultrasound microscopy fields. The Company markets its products to ophthalmologists, optometrists, universities, and clinics throughout the United States and internationally.

This press release contains statements that, if not verifiable historic fact, may be viewed as forward-looking statements that could predict future events and outcomes with respect to Paradigm and its business. The predictions embodied in these statements will involve risk and uncertainties and, accordingly, actual results may differ significantly from the results discussed or implied in such forward-looking statements.Contact: Stephen L. Davis President and Chief Executive Officer801-977-8970 www.paradigm-medical.com
'/>"/>

SOURCE Paradigm Medical Industries, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. New White Paper for Dietary Supplement Manufacturers Provides How-to for New FDA Compliance Paradigm
2. Molecular Devices Releases Breakthrough TUNE Technology, Now Part of the SpectraMax® Paradigm® Multi-Mode Microplate Detection Platform
3. Paradigm is Successful at Annual Vision Source Meeting in Houston, Texas
4. RSB Spine, LLC, Announces Distribution Agreement with Paradigm BioDevices, Inc.
5. Study Results Present Paradigm Shift; REDUCE Trial Shows New Hope for the Risk Reduction of Prostate Cancer
6. Changing Paradigms in Hereditary Angioedema: A Focus on Prompt Diagnosis and New Therapies
7. Topical Treatment for Cold Sores Achieves Efficacy of Oral Drugs; Represents Paradigm Shift in the Treatment of Skin Infections
8. Hybrid Fuels, Inc. Announces New Business Strategy
9. Millstone Medical Outsourcing Hires Veteran VP of Business Development to Support OEMs from Warsaw, IN
10. NCPA Launches Initiative to Help Independent Community Pharmacies Create Better Business Opportunities for Front-End Merchandise
11. Ultragenyx Appoints Tom Kassberg as Chief Business Officer and Announces Management Team
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/25/2016)... , May 25,2016 FDA ... near-infrared Cellvizio platform for urological and surgical applications ... MKEAY) inventor of Cellvizio®, the multidisciplinary confocal laser ... milestone in the US with the 12 th ... Drug Administration (FDA). This new FDA clearance covers ...
(Date:5/25/2016)... , Germany and GERMANTOWN, ... QIAGEN N.V. (NASDAQ: QGEN ; Frankfurt Prime Standard: ... licensing and co-development agreement with Therawis Diagnostics GmbH to develop ... be to develop and market PITX2 as a marker to ... high-risk breast cancer patients. "We are pleased to ...
(Date:5/25/2016)... According to market research "Global ... Demand Forecast to 2022 - Industry Insights by Type ... by P&S Market Research, the global insulin delivery device ... it is expected to grow at a CAGR of ... segment is expected to witness the fastest growth at ...
Breaking Medicine Technology:
(Date:5/26/2016)... ... 26, 2016 , ... Catalent Pharma Solutions, the leading global ... and global clinical supply services, today announced two key appointments and the opening ... and strategic growth plans in the Asia Pacific region. , Howard Kim has ...
(Date:5/26/2016)... CA (PRWEB) , ... May 26, 2016 , ... In an effort to provide hair ... available to both Snapchat users and those who do not use the app. Dr. Mohebi, ... his new page, Dr. Mohebi Live . , Dr. Mohebi says, “The positive ...
(Date:5/26/2016)... ... May 26, 2016 , ... ... for eating disorders, is opening a brand new child and adolescent residential treatment ... and their families with even more specialized eating disorder treatment and access to ...
(Date:5/26/2016)... ... May 26, 2016 , ... ... multitude of activities from daily practices, arts & crafts, discussions, and games all ... East-D’Anna and Christy Evans have combined backgrounds in kids’ yoga, collegiate sport yoga ...
(Date:5/26/2016)... ... May 26, 2016 , ... Eugene Batelli, ... Along with his wonderful accolades and stellar patient reviews, Dr. Batelli continues to ... , Dr. Eugene Batelli is a highly trained Podiatric Surgeon who specializes in ...
Breaking Medicine News(10 mins):